02-07-2026 19:03 via pharmacypracticenews.com

Emerging Therapies For Blood Cancers

Christie Denton, PharmD, BCPSClinical Assistant Professor/Drug Information SpecialistUniversity of Illinois at Chicago College of PharmacyLeukemia, lymphoma, and myeloma, the 3 main types of blood cancers, account for about 10% of new cancer diagnoses each year.1 In 2024, 187,740 new cases of leukemia, lymphoma, and myeloma were estimated to be diagnosed, with approximately 57,260 deaths expected. Advances in treatment for blood cancers have led to guideline updates, expanded indications for sev
Read more »

Pharmacy news



As Medicare’s GLP-1 Bridge Program Launches, ISMP Offers Guidance for Pharmacists
Omadacycline Trial Offers a Rare Win for NTM, While Shorter TB Treatment Regimens Are Limited by Toxicities
Rethinking Inpatient IV Default for PWID With Serious Injection-Related Infections
ASHP Futures 2026: Tips for Hazardous Drug Wipe Sampling
Pediatric Iron Deficiency: New Ferritin Thresholds, and a Wider Role for Pharmacy
IV Iron During Acute Infection Linked to Lower Mortality, Real-World Analysis Finds
Action Steps for Reimbursement Readiness
ASHP Futures 2025: Medication Safety in the AI Era
A Plague on Patient Assistance
Decnupaz Approved for Blastic Plasmacytoid Dendritic Cell Neoplasms
ASHP Futures 2026: Proactive Tools to Modernize Medication Safety
As Manufacturers Catch On to Alternative Funding Programs, More Specialty Patients Routed to Overseas Pharmacies
Ambulatory Care Pharmacists Drive Higher Specialty Prescription Capture
ASHP Calls on HHS to Halt Lilly’s 340B Data Cutoff
Desktop versie